Sigyn Therapeutics, Inc. (OTCMKTS:SIGY – Get Free Report)’s share price traded up 1.6% on Thursday . The company traded as high as $3.20 and last traded at $3.20. 140 shares traded hands during trading, an increase of 165% from the average session volume of 53 shares. The stock had previously closed at $3.15.
Sigyn Therapeutics Stock Performance
The firm has a 50 day simple moving average of $4.29 and a two-hundred day simple moving average of $5.07.
Sigyn Therapeutics Company Profile
Sigyn Therapeutics, Inc, a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats.
Featured Stories
- Five stocks we like better than Sigyn Therapeutics
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- Expert Stock Trading Psychology Tips
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- The 3 Best Blue-Chip Stocks to Buy Now
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Sigyn Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sigyn Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
